Evaluation of spot urine as an alternative to 24h urine collection for determination of biomarkers of exposure to cigarette smoke in adult smokers

Environmental Toxicology and Pharmacology

Volumn 36, Issue 1, 2013, Pages 108-114

  Sarkar, Mohamadi ^a   Muhammad Kah, Raheema ^a   Liang, Qiwei ^a   Kapur, Sunil ^a   Feng, Shixia ^a   Roethig, Hans ^a  

^a Altria Client Services Inc   (United States)

Author keywords

24 h urine; Biomarkers; Exposure evaluation; Model; Smoking; Spot urine

Indexed keywords

1 HYDROXYPYRENE GLUCURONIDE; 1 HYDROXYPYRENE SULFATE; 1,3 BUTADIENE; 3 HYDROXYPROPYLMERCAPTURIC ACID; 3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL GLUCURONIDE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETYLCYSTEINE; ACROLEIN; BENZENE; BIOLOGICAL MARKER; COTININE; COTININE N GLUCURONIDE; CREATINE; GLUCURONIDE; MONOHYDROXYBUTYLMERCAPTURIC ACID; NICOTINE; NICOTINE N GLUCURONIDE; PHENYLMERCAPTURIC ACID; PYRENE; SULFATE; TRANS 3' HYDROXYCOTININE O GLUCURONIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; SMOKING; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; SMOKING; TANDEM MASS SPECTROMETRY; TIME FACTORS; URINE SPECIMEN COLLECTION; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 84876736416     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2013.03.001     Document Type: Article

References (28)

1. Andersson L., Haraldsson B., Johansson C., Barregard L. Methodological issues on the use of urinary alpha-1-microglobuline in epidemiological studies. Nephrol. Dial. Transplant. 2008, 23:1252-1256.
2. Araki S., Sata F., Murata K. Adjustment for urinary flow rate: an improved approach to biological monitoring. Int. Arch. Occup. Environ. Health 1990, 62:471-477.
3. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
4. Boeniger M.F., Lowry L.K., Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am. Ind. Hyg. Assoc. J. 1993, 54:615-627.
5. Burtis C.A., Ashwood E.R. Tietz Textbook of Clinical Chemistry 1999, W.B. Waunders Company, Philadelphia.
6. Carrieri M., Trevisan A., Bartolucci G.B. Adjustment to concentration-dilution of spot urine samples: correlation between specific gravity and creatinine. Int. Arch. Occup. Environ. Health 2001, 74:63-67.
7. Cheng H., Sathiakumar N., Graff J., Matthews R., Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem. Biol. Interact. 2007, 166:15-24.
8. Dor F., Dab W., Empereur-Bissonnet P., Zmirou D. Validity of biomarkers in environmental health studies: the case of PAHs and benzene. Crit. Rev. Toxicol. 1999, 29:129-168.
9. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., Riedel K. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,transmuconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 2006, 11:28-52.
10. Green C.R., Rodgman A. The Tobacco Chemists' Research Conference: a half century forum for advances in analytical methodology of tobacco and its products. Recent Adv. Tob. Sci. 1996, 22:131-304.
11. Hatsukami D.K., Lemmonds C., Zhang Y., Murphy S.E., Le C., Carmella S.G., Hecht S.S. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J. Natl. Cancer Inst. 2004, 96:844-852.
12. Heavner D.L., Morgan W.T., Sears S.B., Richardson J.D., Byrd G.D., Ogden M.W. Effect of creatinine and specific gravity normalization techniques on xenobiotic biomarkers in smokers' spot and 24-h urines. J. Pharm. Biomed. Anal. 2006, 40:928-942.
13. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999, 91:1194-1210.
14. Hecht S.S. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002, 23:907-922.
15. Liang Q., Sarkar M. Intra- and inter-individual variability in urinary nicotine excretion and plasma cotinine in adult cigarette smokers. Regul. Toxicol. Pharmacol. 2012, 64:388-393.
16. Lin L., Torbeck L.D. Coefficient of accuracy and concordance correlation coefficient: new statistics for methods comparison. PDA J. Pharm. Sci. Technol. 1998, 52:55-59.
17. Mascher D.G., Mascher H.J., Scherer G., Schmid E.R. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 750:163-169.
18. Mason H.J., Williams N.R., Morgan M.G., Stevenson A.J., Armitage S. Influence of biological and analytical variation on urine measurements for monitoring exposure to cadmium. Occup. Environ. Med. 1998, 55:132-137.
19. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., Liang Q. Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2007, 47:518-530.
20. Sarkar M., Kapur S., Frost-Pineda K., Feng S., Wang J., Liang Q., Roethig H.J. Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon filtered cigarettes in short term and long term clinical studies. Nicotine Tob. Res. 2008, 1-12.
21. Sarkar M., Wang J., Liang Q. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) in menthol and non-menthol cigarette smokers. Drug Metab. Lett. 2012.
22. Scherer G. Biomonitoring of inhaled complex mixtures - ambient air, diesel exhaust and cigarette smoke. Exp. Toxicol. Pathol. 2005, 57(Suppl. 57):75-110.
23. Scherer G., Frank S., Riedel K., Meger-Kossien I., Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol. Biomarkers Prev. 2000, 9:373-380.
24. Stratton K., Shetty P., Wallace R., Bondurant S. Clearing the smoke: the science base for tobacco harm reduction - executive summary. Tob. Control 2001, 10:189-195.
25. Strickland P., Kang D. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol. Lett. 1999, 108:191-199.
26. Strickland P., Kang D., Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ. Health Perspect. 1996, 104(Suppl. 5):927-932.
27. Tamamizu-Kato S., Wong J.Y., Jairam V., Uchida K., Raussens V., Kato H., Ruysschaert J.M., Narayanaswami V. Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E. Biochemistry 2007, 46:8392-8400.
28. Urban M., Gilch G., Schepers G., van Miert E., Scherer G. Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 796:131-140.